The pharma industry has been relatively slow to embrace concepts such as Industry 4.0, but COVID-19 is serving as a catalyst for sweeping changes within the industry.
The philosophy has roots in a German framework that prioritizes digitization to drive manufacturing efficiency, promising that cyber-physical systems will usher in the next industrial revolution. The Industry 4.0 framework spans connectivity, analytics and AI and integrated automation technologies.
But the deployment of Industry 4.0–inspired technologies has been uneven in the pharma industry. “The industry is pretty cautious,” said John Younes, COO of Litmus Automation, the developer of an industrial edge computing platform.
Get the full story from our sister site, Pharmaceutical Processing World.